CA2289253A1 - Vaccin anti-helicobacter administrable par voie generale sous-diaphragmatique, et procede combine d'immunisation par les muqueuses/parenterale - Google Patents

Vaccin anti-helicobacter administrable par voie generale sous-diaphragmatique, et procede combine d'immunisation par les muqueuses/parenterale Download PDF

Info

Publication number
CA2289253A1
CA2289253A1 CA002289253A CA2289253A CA2289253A1 CA 2289253 A1 CA2289253 A1 CA 2289253A1 CA 002289253 A CA002289253 A CA 002289253A CA 2289253 A CA2289253 A CA 2289253A CA 2289253 A1 CA2289253 A1 CA 2289253A1
Authority
CA
Canada
Prior art keywords
helicobacter
route
use according
immunogenic agent
immune response
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002289253A
Other languages
English (en)
Inventor
Bruno Guy
Jean Haensler
Cynthia K. Lee
Richard A. Weltzin
Thomas P. Monath
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
MERIEUX ORAVAX
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9705609A external-priority patent/FR2762788B1/fr
Application filed by MERIEUX ORAVAX filed Critical MERIEUX ORAVAX
Publication of CA2289253A1 publication Critical patent/CA2289253A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention porte sur l'utilisation d'un agent immunogène dérivant de l'Helicobacter dans la fabrication de préparations pharmaceutiques suscitant une réponse immunitaire du type T-1 (Th1) anti Helicobacter afin de prévenir ou traiter une infection par l'Helicobacter chez un mammifère. On y parvient en particulier lorsqu'on envisage d'administrer la composition par voie générale ou parentérale par exemple dans la région du mammifère située sous le diaphragme. L'invention porte également sur un procédé combiné d'immunisation, par les muqueuses/parentérale, pour prévenir ou traiter les infections par l'Helicobacter.
CA002289253A 1997-04-30 1998-04-30 Vaccin anti-helicobacter administrable par voie generale sous-diaphragmatique, et procede combine d'immunisation par les muqueuses/parenterale Abandoned CA2289253A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR9705609A FR2762788B1 (fr) 1997-04-30 1997-04-30 Composition vaccinale anti-helicobacter pour usage par voie systemique sous-diaphragmatique
FR97/15731 1997-12-08
FR9715731 1997-12-08
FR97/05609 1997-12-08
PCT/US1998/008890 WO1998048835A1 (fr) 1997-04-30 1998-04-30 Vaccin anti-helicobacter administrable par voie generale sous-diaphragmatique, et procede combine d'immunisation par les muqueuses/parenterale

Publications (1)

Publication Number Publication Date
CA2289253A1 true CA2289253A1 (fr) 1998-11-05

Family

ID=26233514

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002289253A Abandoned CA2289253A1 (fr) 1997-04-30 1998-04-30 Vaccin anti-helicobacter administrable par voie generale sous-diaphragmatique, et procede combine d'immunisation par les muqueuses/parenterale

Country Status (10)

Country Link
EP (1) EP1017417A1 (fr)
JP (1) JP2002512619A (fr)
KR (1) KR20010020366A (fr)
CN (1) CN1254292A (fr)
AU (1) AU751433B2 (fr)
BR (1) BR9809426A (fr)
CA (1) CA2289253A1 (fr)
HU (1) HUP0003388A3 (fr)
NO (1) NO995290L (fr)
WO (1) WO1998048835A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0029919D0 (en) * 2000-12-07 2001-01-24 Chiron Spa Helicobacter pylori prime & boost vaccination
ES2569907T3 (es) 2008-06-27 2016-05-13 Zoetis Services Llc Composiciones adyuvantes novedosas
UA130246C2 (uk) 2013-09-19 2025-12-31 Зоетіс Сервісіз Ллс Ад'ювант на основі олії
CN115317600A (zh) 2015-01-16 2022-11-11 硕腾服务有限责任公司 口蹄疫疫苗
CN108743929B (zh) * 2018-06-14 2021-07-27 四川大学 一种用作尿素清除剂的脲酶凝胶微球的制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69333110T2 (de) * 1992-03-02 2004-05-06 Chiron S.P.A. Mit dem cytotoxin von helicobacter pylori assoziiertes, immunodominantes antigen verwendbar in impfstoffen und zur diagnose
US5679769A (en) * 1994-03-15 1997-10-21 Sloan-Kettering Institute For Cancer Research Synthesis of asparagine-linked glycopeptides on a polymeric solid support
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
US5610060A (en) * 1994-06-24 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Isolated Helicobacter hepaticus
AR003125A1 (es) * 1995-06-01 1998-07-08 Astra Ab Antigenos bacterianos para el diagnostico de infecciones con helicobacter pylori, una molecula de adn que lo codifica, un vector, una celula huesped,procedimiento para producir el polipeptido, composiciones para vacunas adecuadas para uso terapeutico y profilactico, el uso del polipeptido en la
SK165197A3 (en) * 1995-06-07 1999-01-11 Astra Ab Nucleic acid and amino acid sequences relating to helicobacter pylori for diagnostics and therapeutics

Also Published As

Publication number Publication date
NO995290L (no) 1999-12-29
KR20010020366A (ko) 2001-03-15
HUP0003388A3 (en) 2001-06-28
HUP0003388A2 (hu) 2001-02-28
CN1254292A (zh) 2000-05-24
EP1017417A1 (fr) 2000-07-12
WO1998048835A1 (fr) 1998-11-05
JP2002512619A (ja) 2002-04-23
AU7276898A (en) 1998-11-24
NO995290D0 (no) 1999-10-29
AU751433B2 (en) 2002-08-15
BR9809426A (pt) 2000-06-13

Similar Documents

Publication Publication Date Title
EP0771214B1 (fr) Traitement et prevention d'infections causees par les bacteries du genre helicobacter
Mielcarek et al. Nasal vaccination using live bacterial vectors
JP2003509469A (ja) 経口用組換え乳酸桿菌ワクチン
CA3063419A1 (fr) Vecteurs de salmonella typhi vivants modifies pour exprimer des antigenes de proteines de membrane externe heterologues et leurs procedes d'utilisation
JP5745731B2 (ja) サルモネラワクチン
AU750379B2 (en) Anti-helicobacter vaccine composition comprising a Th1 adjuvant
AU751433B2 (en) Anti-(helicobacter) vaccine composition for use by the subdiaphragmatic systemic route, and combined mucosal/parenteral immunization method
US9119803B2 (en) Carious tooth vaccine and preparation method
Medaglini et al. Recombinant Gram-positive bacteria as vehicles of vaccine antigens
WO1995027508A1 (fr) Composition utilisable pour induire une reponse immunitaire
US20040033240A1 (en) Immunological combinations for prophylaxis and therapy of helicobacter pylori infection
MXPA99009915A (es) Composicion de vacuna anti-helicobacter para usomediante la ruta sistematica sub-diafragmatica, ymetodo de inmunizacion mucosal/parenteral combinado
CZ361799A3 (cs) Použití imunogenní látky odvozené od bakterie rodu Helicobacter a způsob prevence nebo léčby infekcí způsobených těmito bakteriemi
JPH11240844A (ja) 肺炎球菌抗原の経口投与
Harada et al. Development of a mucosal complex vaccine against oral Salmonella infection in mice
JP2009078995A (ja) 歯周病用免疫ワクチン
FR2762788A1 (fr) Composition vaccinale anti-helicobacter pour usage par voie systemique sous-diaphragmatique
AU702878B2 (en) Treatment and prevention of helicobacter infection
JP2023516397A (ja) タンパク質抗原を発現するように操作される生チフス菌ベクターおよびその使用方法
El-Gewely Donata Medaglini1, Susanna Ricci¹, Tiziana Maggi1, Catherine M. Rush1
FR2762787A1 (fr) Composition vaccinale anti-helicobacter comprenant un adjuvant de type th1
Kotloff et al. Vaccine Strategies Against Helicobacter Pylori
Hl-Gewely Donata Medaglini", Susanna Ricci", Tiziana Maggi", Catherine M. Rush"
WO1998049318A1 (fr) Composition vaccinale anti-helicobacter a base d'adn
AU2249900A (en) Composition for inducing a mucosal immune response

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued